Showcase of our trial-ready technology, GlucoBeam

We will exhibit our cutting-edge non-invasive glucose monitor, GlucoBeam at ATTD 2019 

ATTD, one of the world’s leading scientific forums for showcasing the latest breakthroughs in diabetes technology, will be held in Berlin later this week. Set to make our first conference appearance as an exhibitor at the prestigious New Technologies Fair, we will unveil the version of GlucoBeam to be used in our upcoming pivotal trial, a key step towards obtaining regulatory approval in Europe.

The technology represents the culmination of over 10 years of research and testing to integrate the company’s proprietary critical depth Raman technology into an all-in-one consumer glucose monitor for daily home-use. While the hardware is similar to the future commercial version, the software is still being finalised in preparation for GlucoBeam’s market launch.

We are extremely excited about the opportunity to introduce RSP Systems to industry specialists, scientists and key opinion leaders at ATTD and to showcase our trial-ready technology. We are looking forward to making the premium consumer version of GlucoBeam available to the public soon.

Anders Weber, CSO will be giving a talk at the fair and we will be present at Booth 42.


Share on facebook
Share on twitter
Share on linkedin

More news

RSP Systems big move

We have just moved to our own building! A short kilometer away from our previous shared building, we have literally been up …

RSP Systems Secures Series B Funding to Drive its Non-Invasive Glucose Monitor Odense, Denmark, June 11, 2018 / B3C newswire / — RSP Systems A/S, …

New CEO appointed

We are delighted to announce that the Board has appointed Anders Weber CEO of RSP Systems early this month. Anders brings business …